Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …

Graft-versus-host disease is among the most common clinical complications following
allogeneic hematopoietic stem cell transplantation. It causes inflammation-mediated …

Graft‐versus‐host disease (GVHD) is a systemic disease that can affect multiple organs as a
consequence of an allogeneic haematopoietic stem cell transplant. One organ system that is …

Purpose: To study the outcomes of cataract surgery in patients with graft-versus-host
disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Methods …

Background Chronic ocular graft-versus-host disease (oGVHD) is an ocular comorbidity of
graft-versus-host disease (GVHD) that usually occurs concurrently with systemic …

Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two
decades to become the standard of care for hematologic and lymphoid malignancies. Major …

We studied 172 patients for development of ocular graft-versus-host disease (GVHD) after
allogeneic stem cell transplantation (allo-SCT) from 2002 to 2009. Ocular GVHD was …

Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after
hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting …

PURPOSE To evaluate the incidence, clinical characteristics, microbiological profile, and
therapeutic outcomes of corneal ulcers in individuals with chronic ocular graft-vs-host …

We investigate long-term clinical outcomes and predictive factors associated with poor
vision outcomes in patients with ocular graft-versus-host disease (oGVHD). This …